Research & Development



  這個老家伙打了一輩子的仗都沒有死掉,應該死在即將享受富貴榮華之前!   如果於單打下了白登山,單于的位子就跟伊秩斜沒有什麼關系了,伊秩斜想要當單于,他就只能在於單勝利之前成為匈奴的單于。毛片基地   雲瑯覺得這道禁令其實就是對他一個人下的,謝長川,裴炎,孟度等一干老將完全不在這個無關人等範疇之內。色姐妹综合网   “那就烤包子……?”雲瑯有些不確定的道。   謝長川把最後一個包子丟進嘴里,也不見他嚼,那麼大的包子就被他給吞下去了。亚州性夜夜射   什長嘿嘿笑道︰“反正卑職什麼都不知道,大帥問起來也自然是一問三不知!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo